ViiV Healthcare is a company 100% focussed on HIV, and as such, we are looking to move beyond our medicines, delivering and supporting new programmes that can help tackle the challenges of the HIV epidemic in an impactful way.
We are committed to a united effort to achieve the UNAIDS 90-90-90 goal of improving care and having an AIDS free generation by 2030. To ensure this, variations in management and care across the HIV care continuum need to be addressed.
To this end, ViiV Healthcare and its partners have developed a number of initiatives, including Positive Pathways for HIV care—a program intended to define best practice and interventions that can effectively close the gaps in the treatment cascade.
Through a series of external collaborations and partnerships with multiple stakeholders, we aim to evaluate various models of practice and test new interventions that will help to build the body of evidence in HIV implementation science.
Implementation science[i] is a multidisciplinary specialty that seeks generalisable knowledge about the behaviour of stakeholders, organisations, communities and individuals, in order to understand the scale of, reasons for and strategies to close the gap between evidence and routine practice for help in real world contexts.
"We live in a time of highly efficacious antiretrovirals, where people living with HIV (PLHIV) can have a normal life expectancy and the spread of the epidemic can be stopped. Despite this, substantial gaps remain across the whole care continuum. Only through effective strategies that address the challenges of delivering management and care in real world settings, can we achieve our global aim of an AIDS free generation." Dr Eric LeFevre, Medical Director, ViiV Healthcare.
As a leader in HIV, ViiV Healthcare is committed to making significant contributions to implementation science, consistent with our mission of leaving no patient behind.